An alternative to bypass surgery

[FNG]

Tweethttps://www.google.com/m/url?client=m...hwzsgP9gmDL1Zg

if I can I may give this a go it's said to benefit type II diabetics which I once was and to benefit your liver, kidneys, and circulatory system.

[FUZO]

TweetWe all should give some type of help to this

[Dzone]

TweetIm interested to see what it is. Wont load on this internet modem so will have to load it at my office...is it something to do with chelation therapy?

[FNG]

TweetYup it's chelation therapy from the Swiss. It seems that they have an oral as well, but it's to expensive for me. The plaquex IV treatment in BC runs 150 per session while in Mexico it's 60 per session. I haven't called anyone in GTA.

The Oral version
https://www.plaquex.net/Downloads/Pla...%20Studies.pdf
Contents
Active ingredient per serving:
520 Soy Lecithin with 61 % Phosphatides
Serving size: 2 softgels
Other ingredients: Gelatine, Vegetable Glycerin, Purified Water
Indications *
- Hypercholesterolemia
- Hyperlipoproteinaemia
- Promotes healthy liver function
- Increased platelet aggregation
- Decreased blood rheology
Dosage
3 x daily 2 gel caps before meals
Side effects
Slight gastrointestinal disturbance (stomach), diarrhea
Pharmacokinetics
The relative absorption rates of radioactive PPC in man are higher than 90 %. About 40 to
80 % of the PPC absorbed are incorporated into the vasoprotective HDL. EPL accumulated chiefly in the liver, spleen and lungs and phospholipid fractions of the serum lipoproteins were exchanged for EPL from the serum. The mean elimination rates from the plasma after 15 minutes, 75 minutes and 10 h are approx. 80 %, 92 % and 99 % of the administered active principle.
Chemistry
Essential phospholipids (EPL) are a highly purified phosphatidylcholine fraction isolated from soy beans. The substance is particularly rich in polyunsaturated fatty acids, with linoleic acid accounting for approx. 70 % and is therefore also termed polyenylphosphatidylcholine (PPC).
Study summaries
1. Reduction of serum lipids
By diet an increase of serum lipids was triggered for 2 to 8 weeks. Then EPL was introduced and serum lipids monitored:
•
HDL increased
•
LDL, TG, VLDL decreased
Investigation on Rhesus monkeys after a 10-year period of high cholesterol diet and a 7 week period of EPL application.
Assessment of serum total cholesterol, LDL, HDL and TG at baseline, 7 weeks after start of EPL and 16 weeks after completion of EPL.
Effects on Lipoproteins
The action of EPL was reflected in an increase of HDL cholesterol and a decrease in LDL cholesterol, VLDL triglycerides as well as reduced ratio of LDL/HDL cholesterol.
Effects on serum cholesterol:
In the majority of trials an average reduction of total serum cholesterol by 12 to 19 % was observed under treatment with EPL; in some of the trial groups mean values were reduced by more than 20 % as against initial values, yet others were lowered by 7 to 10 % only.
In a documentation of 15 clinical trials with a duration of EPL treatment ranging between 1 and 12 months, total serum cholesterol was lowered by 8.8 to 28.2% (107). The level of initial values, the route of administration, EPL dosage and duration of treatment seem to be the main determinants for the slope of the reduction. Nine to 20 days of intravenous EPL treatment for instance, already caused a reduction of total serum cholesterol of approx. 13 % (91,92,95,144 and 146).
An initially simultaneous administration of EPL ampoules and capsules led to a pronounced decrease in cholesterol (82); the author had introduced treatment on a dosage scheme of 250 mg i.v. + 875 mg orally and observed a further, though markedly slower decrease in cholesterol concentration when continuing treatment on oral EPL alone (chart below)................